Table: Jcr Pharmaceuticals -2025/26 group forecast
11/05/2026 07:33
May 11 (Reuters) -
Jcr Pharmaceuticals Co., Ltd.
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Mar 31, 2026 Mar 31, 2026
LATEST PREVIOUS
FORECAST FORECAST
Sales 40.30 39.50
Operating 500 mln 400 mln
Recurring 1.10 400 mln
Net 2.10 1.60
EPS 17.87 yen 13.12 yen
NOTE - Jcr Pharmaceuticals Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4552.T
Recent news on JCR Pharmaceuticals
See all newsBrief: JCR Pharmaceuticals Receives Marketing Authorization In Kuwait For Izcargo
Italfarmaco And Jcr Pharmaceuticals Enter Into Exclusive License Agreement For Jr-141 In United States, Europe, And Latin America
Brief: Jcr Pharmaceuticals Receives Orphan Drug Designation For Givinostat In Japan
Brief: Medipal & JCR Dose First Patient In Global Phase I/II Trial OF JR-446 For Mucopolysaccharidosis Type IIIB
Table: Jcr Pharmaceuticals -Q1 group results